November 25th 2024
Your daily dose of the clinical news you may have missed.
November 11th 2024
AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.
October 9th 2024
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
September 18th 2024
August 30th 2024
ESC 2024: Cannabis, opioid, and MDMA use were most strongly tied to cardiovascular event risk, according to a new study.
High-Intensity Interval Training May Improve Cardiorespiratory Fitness After Stroke
Findings from a new study suggest high-intensity interval training may be more effective in improving individuals’ cardiorespiratory fitness poststroke than moderate-intensity continuous training.
Sugar Substitute Raises Risk of Major Adverse Cardiovascular Events: Daily Dose
Adolescent Obesity Linked to Higher Stroke Risk in Women: Daily Dose
Women with Overweight/Obesity as Teens, Young Adults Face Higher Risk of Cerebrovascular Disease Later in Life
In contrast, men did not face the same increased risk of cerebrovascular disease later in life, reported authors of a new study.
CV Risk Prevention Profiles Significantly Worse Following Stroke vs MI in 2 Large National Cohorts
Study participants who had a history of stroke were nearly 60% less likely to meet guideline-recommended secondary prevention goals, new research reveals.
Nontraditional Risk Factors More Likely to Cause Stroke in Young Adults, Study Finds
Migraine was the most important nontraditional risk factor linked to stroke in adults aged 18 to 34 years and should be considered in evaluation for an event.
Stroke Risk Mitigated by Low Levels of Exercise: Daily Dose
Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose
Risk of Stroke Mitigated by Even Low Levels of Physical Activity
Even activity levels considered "insufficient" by guideline standards were found protective against stroke in this new systematic review and meta-analysis.
Weak in the Legs and Lips: Seen in the ED
A man in his eighties presents to the ED after 1 week of persistent bilateral leg weakness and dysgeusia that has not worsened. What's your Dx?
Migraine, Persistent VMS Tied to Higher Risk of CVD, Stroke: Daily Dose
Plastic Debris Detected in Carotid Plaque Linked to Higher Risk for MI, Stroke, Death
Patients who had microplastics and nanoplastics in their carotid plaque were at more than a fourfold risk for MI, stroke, or death compared to those who did not, according to a new study.
Cannabis Use Associated with Higher Risk of MI, Stroke: Daily Dose
Migraine and Persistent Vasomotor Symptoms Linked to Higher Risk of CVD, Stroke in Analysis of CARDIA Study
Women with migraine and persistent VMS faced double the risk of CVD and triple the risk of stroke, reported researchers.
Marijuana Use Linked to Higher Risk of Myocardial Infarction, Stroke in New Study
The risk for cardiovascular outcomes increased with more frequent reported cannabis use per month, according to results from a large national study.
Functional Deficits Poststroke Found More Pronounced in Study Group with Lower Mean Oxygen Saturation During Sleep
At 3 months following ischemic stroke, lower mean oxygen saturation but not apnea-hypopnea index was associated with functional deficits, according to a French research team.
Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose
Apixaban and Aspirin Appear Equal Against Recurrent Stroke in Individuals with Cardiopathy
Anticoagulation and antiplatelet therapy appeared equally effective in reducing risk of recurrent stroke following cryptogenic stroke in persons with evidence of atrial cardiopathy.
Apixaban Reduced Risk of Stroke in Subclinical Afib Relative to Aspirin but with Greater Risk of Bleeding: ARTRESIA Trial
In apixaban-treated participants, risk of stroke or systemic embolism was reduced by 37%; the risk of disability or fatal stroke declined by 49%, but with noted bleeding risk.
Among Black Women, Hypertension Before Age 30 Years May Triple Risk of Later Stroke
The 3-fold greater risk of subsequent stroke was observed in the Black Women's Health Study's youngest cohort, aged 24-34, investigators reported.
More than Half of US Adults Still Don't Recognize Heart Disease as #1 Cause of Death
Heart disease has been the primary cause of death in the US for the last century, and yet 51% of adults do not recognize the fact.
Daily Dose: Bempedoic Acid Linked to 20% Reduction in Total CV Events
Bempedoic Acid Associated with 20% Reduction in Total CV Events in Prespecified CLEAR Outcomes Analysis
The protective effect of bempedoic acid appeared to increase with the number of CV events a study participant experienced, according to study authors.
Milvexian Added to Standard DAPT Fails to Reduce Stroke Risk, May Increase Risk of Bleeding
AXIOMATIC-SSP is considered the largest clinical trial of activated factor XIa inhibition added to standard antiplatelet therapy for secondary stroke prevention.
10 Questions on Adult Blood Pressure Targets Based on AAFP Guidelines
The 2022 AAFP Clinical Practice Guideline on hypertension treatment in adults is the subject matter for this 10-question topline quiz that is also a good source of review.
Daily Dose: Worldwide Burden of Atrial Fibrillation Doubled Over 30 Years
Your daily dose of clinical news you may have missed.
The Worst States for Health Care in the US: 2023
Get a quick look at the US worst states for health care ranked using a composite score that included measures of cost, access, and outcomes.
Worldwide Burden of Atrial Fibrillation More Than Doubled Over 30 Years: Global Analysis
Atrial fibrillation prevalence is rising across socioeconomic strata globally, the new analysis finds, with effects of BMI, ETOH, and sedentary behavior shifting as key drivers.
Frail Elderly at High Risk of Bleeding Following VKA-DOAC Switch: Surprise Outcome Shared at ESC Congress
Oldest and most frail elderly were at more than 60% greater risk of bleeding when switched from a VKA than those who remained on the traditional agent.
Antiobesity Medication Semaglutide 2.4 mg Reduced Risk of MACE by 20%: Topline Results from Landmark SELECT Trial
The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."
